0000899243-19-009014.txt : 20190327 0000899243-19-009014.hdr.sgml : 20190327 20190327160529 ACCESSION NUMBER: 0000899243-19-009014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190325 FILED AS OF DATE: 20190327 DATE AS OF CHANGE: 20190327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Telling Fred CENTRAL INDEX KEY: 0001382225 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32188 FILM NUMBER: 19708443 MAIL ADDRESS: STREET 1: 501 ELLIOTT AVE. W. STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-25 0 0001174940 ORAGENICS INC OGEN 0001382225 Telling Fred 4902 EISENHOWER BOULEVARD TAMPA FL 33634 1 0 0 0 Common Stock 2019-03-25 4 P 0 100000 A 339538 D Series 1 Common Stock Warrants (right to buy) 0.75 2019-03-25 4 P 0 50000 A 2019-03-25 2020-09-25 Common Stock 50000 50000 D Series 2 Common Stock Warrants (right to buy) 0.90 2019-03-25 4 P 0 50000 A 2019-03-25 2024-03-25 Common Stock 50000 50000 D Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units. /s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling 2019-03-27